术中在体共聚焦激光显微内镜成像在胶质瘤边缘:能否检测肿瘤浸润?
该研究从两家机构采集胶质瘤边缘感兴趣区的在体共聚焦激光显微内镜(CLE)图像与配对组织活检,由4名神经病理学家按0–5分评分系统评估CLE与H&E图像,并将ROI分为低肿瘤概率组(0–2分)与高肿瘤概率组(3–5分)。结果显示CLE与H&E评分一致率为61.6%,敏感度79%、特异度37%,CLE图像评分者间信度仅为中等。作者认为CLE可能检测胶质瘤边缘肿瘤浸润,但目前尚不可靠。
要点
- CLE与H&E评分一致率61.6%,敏感度79%、特异度37%。
- H&E图像评分者间信度优秀(ICC 0.91),CLE图像仅为中等(ICC 0.69)。
- 高肿瘤概率组的一致率、敏感度和阳性预测值均高于低肿瘤概率组。
核心结论
- CLE可能检测胶质瘤边缘的肿瘤浸润,但目前尚不可靠,尤其在预期肿瘤浸润概率低的情况下。
- 所提出的评分系统内在信度优秀,但用于CLE图像时评分者间信度仅为中等。
- 作者认为该技术作为术中一致可操作指导方法仍需进一步探索;特异性结合和/或肿瘤特异性荧光团、CLE图像图谱及图像解读共识指南可能有助于其转化应用。
研究设计与样本
- 从2家机构采集胶质瘤边缘感兴趣区配对的在体CLE图像与组织活检。
- 所有图像由4名有CLE经验的神经病理学家审阅,采用基于病理特征的0–5分评分系统对CLE和H&E图像评分。
- 根据H&E评分将ROI分为低肿瘤概率组(0–2分)和高肿瘤概率组(3–5分),共分析56个胶质瘤边缘ROI。
主要发现
- H&E图像评分者间信度优秀(ICC 0.91,95%CI 0.86–0.94),CLE图像为中等(ICC 0.69,95%CI 0.40–0.83)。
- 低肿瘤概率组ICC为0.68(95%CI 0.40–0.83),高肿瘤概率组ICC为0.68(95%CI 0.39–0.83),两组无显著差异。
- CLE与H&E评分一致率为61.6%,敏感度79%、特异度37%,阳性预测值65%、阴性预测值53%。
- 高肿瘤概率组的一致率、敏感度和阳性预测值均高于低肿瘤概率组;新诊断组的特异度高于复发组。
关键数值与推荐
- 评分系统:基于病理特征对CLE和H&E图像按0–5分评分。
- 分组阈值:H&E评分0–2分为低肿瘤概率组,3–5分为高肿瘤概率组。
局限性
- CLE图像评分者间信度仅为中等(ICC 0.69,95%CI 0.40–0.83)。
- CLE目前尚不可靠,尤其在预期肿瘤浸润概率低的情况下。
- 作者指出该技术作为一致可操作的术中指导方法仍需进一步探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Confocal laser endomicroscopy (CLE) is a US Food and Drug Administration-cleared intraoperative real-time fluorescence-based cellular resolution imaging technology that has been shown to image brain tumor histoarchitecture rapidly in vivo during neuro-oncological surgical procedures. An important goal for successful intraoperative implementation is in vivo use at the margins of infiltrating gliomas. However, CLE use at glioma margins has not been well studied. METHODS: Matching in vivo CLE images and tissue biopsies acquired at glioma margin regions of interest (ROIs) were collected from 2 institutions. All images were reviewed by 4 neuropathologists experienced in CLE. A scoring system based on the pathological features was implemented to score CLE and H&E images from each ROI on a scale from 0 to 5. Based on the H&E scores, all ROIs were divided into a low tumor probability (LTP) group (scores 0-2) and a high tumor probability (HTP) group (scores 3-5). The concordance between CLE and H&E scores regarding tumor probability was determined. The intraclass correlation coefficient (ICC) and diagnostic performance were calculated. RESULTS: Fifty-six glioma margin ROIs were included for analysis. Interrater reliability of the scoring system was excellent when used for H&E images (ICC [95% CI] 0.91 [0.86-0.94]) and moderate when used for CLE images (ICC [95% CI] 0.69 [0.40-0.83]). The ICCs (95% CIs) of the LTP group (0.68 [0.40-0.83]) and HTP group (0.68 [0.39-0.83]) did not differ significantly. The concordance between CLE and H&E scores was 61.6%. The sensitivity and specificity values of the scoring system were 79% and 37%. The positive predictive value (PPV) and negative predictive value were 65% and 53%, respectively. Concordance, sensitivity, and PPV were greater in the HTP group than in the LTP group. Specificity was higher in the newly diagnosed group than in the recurrent group. CONCLUSIONS: CLE may detect tumor infiltration at glioma margins. However, it is not currently dependable, especially in scenarios where low probability of tumor infiltration is expected. The proposed scoring system has excellent intrinsic interrater reliability, but its interrater reliability is only moderate when used with CLE images. These results suggest that this technology requires further exploration as a method for consistent actionable intraoperative guidance with high dependability across the range of tumor margin scenarios. Specific-binding and/or tumor-specific fluorophores, a CLE image atlas, and a consensus guideline for image interpretation may help with the translational utility of CLE.
引用
- Xu Y, Mathis AM, Pollo B, et al. Intraoperative in vivo confocal laser endomicroscopy imaging at glioma margins: can we detect tumor infiltration? J Neurosurg. 2023. PMID: 37542440. doi:10.3171/2023.5.JNS23546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。